美国非洲裔与美国白人女性良性乳腺疾病与后续三阴性乳腺癌的关联
该回顾性队列分析纳入2588例非洲裔美国女性和3566例美国白人女性,均有活检证实的良性乳腺疾病。非洲裔女性后续发生三阴性乳腺癌的10年概率为0.56%,美国白人女性为0.25%;在发生后续浸润性乳腺癌的患者中,非洲裔女性三阴性乳腺癌比例为24.2%,美国白人女性为7.4%(P=0.01)。非洲裔身份持续为三阴性乳腺癌的显著危险因素。
要点
- 非洲裔女性良性乳腺疾病后10年三阴性乳腺癌概率为0.56%,美国白人女性为0.25%。
- 后续浸润性乳腺癌中,非洲裔女性三阴性乳腺癌占24.2%,美国白人女性占7.4%(P=0.01)。
- 非洲裔身份持续为三阴性乳腺癌的显著危险因素,提示固有易感性。
核心结论
- 非洲裔身份持续为良性乳腺疾病患者后续发生三阴性乳腺癌的显著危险因素,提示其与三阴性乳腺癌发病通路的固有易感性相关。
研究设计与样本
- 回顾性分析纳入2588例非洲裔美国女性和3566例美国白人女性,年龄40至70岁,均有活检证实的良性乳腺疾病诊断,活检标本取自1994年1月1日至2005年12月31日期间。
- 数据来源于亨利福特健康系统(HFHS)病理信息系统,数据分析时间为2015年11月1日至2016年6月15日。
主要发现
- 非洲裔患者后续乳腺癌发生103例(4.1%),平均随访6.8年;美国白人患者发生143例(4.0%),平均随访6.1年。
- 非洲裔患者10年发生三阴性乳腺癌的概率估计为0.56%(95%CI,0.32%-1.0%),美国白人患者为0.25%(95%CI,0.12%-0.53%)。
- 在66例发生后续浸润性乳腺癌的非洲裔患者中,16例(24.2%)为三阴性乳腺癌;在94例有完整生物标志物数据且发生后续浸润性乳腺癌的美国白人患者中,7例(7.4%)为三阴性乳腺癌(P=0.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Compared with white American (WA) women, African American (AA) women have a 2-fold higher incidence of breast cancers that are negative for estrogen receptor, progesterone receptor, and ERBB2 (triple-negative breast cancer [TNBC]). Triple-negative breast cancer, compared with non-TNBC, likely arises from different pathogenetic pathways, and benign breast disease (BBD) predicts future non-TNBC. OBJECTIVE: To determine whether AA identity remains associated with TNBC for women with a prior diagnosis of BBD. DESIGN, SETTING, AND PARTICIPANTS: This study is a retrospective analysis of data of a cohort of 2588 AA and 3566 WA women aged between 40 and 70 years with a biopsy-proven BBD diagnosis. The data-obtained from the Pathology Information System of Henry Ford Health System (HFHS), an integrated multihospital and multispecialty health care system headquartered in Detroit, Michigan-include specimens of biopsies performed between January 1, 1994, and December 31, 2005. Data analysis was performed from November 1, 2015, to June 15, 2016. MAIN OUTCOMES AND MEASURES: Subsequent breast cancer was stratified on the basis of combinations of hormone receptor and ERBB2 expression. RESULTS: Case management, follow-up, and outcomes received or obtained by our cohort of 2588 AA and 3566 WA patients were similar, demonstrating that HFHS delivered care equitably. Subsequent breast cancers developed in 103 (4.1%) of AA patients (mean follow-up interval of 6.8 years) and 143 (4.0%) of WA patients (mean follow-up interval of 6.1 years). More than three-quarters of subsequent breast cancers in each subset were ductal carcinoma in situ or stage I. The 10-year probability estimate for developing TNBC was 0.56% (95% CI, 0.32%-1.0%) for AA patients and 0.25% (95% CI, 0.12%-0.53%) for WA patients. Among the 66 AA patients who developed subsequent invasive breast cancer, 16 (24.2%) developed TNBC compared with 7 (7.4%) of the 94 WA patients who developed subsequent invasive breast cancers and had complete biomarker data (P = .01). CONCLUSIONS AND RELEVANCE: This study is the largest analysis to date of TNBC in the context of racial/ethnic identity and BBD as risk factors. The study found that AA identity persisted as a significant risk factor for TNBC. This finding suggests that AA identity is associated with inherent susceptibility for TNBC pathogenetic pathways.
引用
- Newman LA, Stark A, Chitale D, et al. Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer. JAMA Oncol. 2017. PMID: 28006062. doi:10.1001/jamaoncol.2016.5598
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。